These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20388850)

  • 21. [Knockdown of Grb7 inhibits growth of oral squamous cell carcinoma, cell proliferation and promoted apoptosis through ERK/FOXM1 pathway].
    Liu BY; Cao G; Dong Z; Chen W; Xu JK; Zhang SL; Weng ZQ
    Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):688-693. PubMed ID: 28275791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
    Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetically altered miR‑193a‑3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7.
    Tang Y; Yang S; Wang M; Liu D; Liu Y; Zhang Y; Zhang Q
    Int J Mol Med; 2019 Jun; 43(6):2352-2360. PubMed ID: 31017268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PKC signaling is involved in the regulation of progranulin (acrogranin/PC-cell-derived growth factor/granulin-epithelin precursor) protein expression in human ovarian cancer cell lines.
    Diaz-Cueto L; Arechavaleta-Velasco F; Diaz-Arizaga A; Dominguez-Lopez P; Robles-Flores M
    Int J Gynecol Cancer; 2012 Jul; 22(6):945-50. PubMed ID: 22665040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
    Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
    Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1.
    Qian L; Bradford AM; Cooke PH; Lyons BA
    J Mol Recognit; 2016 Jul; 29(7):318-33. PubMed ID: 26869103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
    Chan DW; Liu VW; Tsao GS; Yao KM; Furukawa T; Chan KK; Ngan HY
    Carcinogenesis; 2008 Sep; 29(9):1742-50. PubMed ID: 18632752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cell migration protein Grb7 associates with transcriptional regulator FHL2 in a Grb7 phosphorylation-dependent manner.
    Siamakpour-Reihani S; Argiros HJ; Wilmeth LJ; Haas LL; Peterson TA; Johnson DL; Shuster CB; Lyons BA
    J Mol Recognit; 2009; 22(1):9-17. PubMed ID: 18853468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mechanistic study on the anti-cancer activity of ethyl caffeate in human ovarian cancer SKOV-3 cells.
    Lee HN; Kim JK; Kim JH; Lee SJ; Ahn EK; Oh JS; Seo DW
    Chem Biol Interact; 2014 Aug; 219():151-8. PubMed ID: 24892518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GRB7 plays a promoting role in the progression of gastric cancer.
    Zhu G; Cai H; Xiao Q; Zeng S; Jiang X; Liu D
    BMC Cancer; 2023 Dec; 23(1):1262. PubMed ID: 38129809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
    Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
    Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The adaptor Grb7 is a novel calmodulin-binding protein: functional implications of the interaction of calmodulin with Grb7.
    Li H; Sánchez-Torres J; del Carpio AF; Nogales-González A; Molina-Ortiz P; Moreno MJ; Török K; Villalobo A
    Oncogene; 2005 Jun; 24(26):4206-19. PubMed ID: 15806159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
    Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
    Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of the calmodulin-binding domain of Grb7 impairs cell attachment to the extracellular matrix and migration.
    García-Palmero I; Villalobo A
    Biochem Biophys Res Commun; 2013 Jun; 436(2):271-7. PubMed ID: 23743201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
    Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion.
    Guo Y; Tian P; Yang C; Liang Z; Li M; Sims M; Lu L; Zhang Z; Li H; Pfeffer LM; Yue J
    Pharm Res; 2015 Mar; 32(3):769-78. PubMed ID: 25823356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GRB7 protein over-expression and clinical outcome in breast cancer.
    Ramsey B; Bai T; Hanlon Newell A; Troxell M; Park B; Olson S; Keenan E; Luoh SW
    Breast Cancer Res Treat; 2011 Jun; 127(3):659-69. PubMed ID: 20635137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.